Latest AI and machine learning research in allergy for healthcare professionals.
To demonstrate the efficacy of machine learning models in predicting mortality in melanoma cancer, w...
Although recent advancements have shed light on the crucial role of coordinated evolution among cell...
Tuberculosis (TB), ranking just below COVID-19 in global mortality, is a highly complex infectious d...
Gefitinib resistance (GR) presents a significant challenge in treating lung adenocarcinoma (LUAD), h...
RATIONALE AND OBJECTIVES: To develop and validate multiple machine learning predictive models incorp...
Immune checkpoint inhibitors (ICIs) are revolutionizing cancer treatment, and Artificial Intelligenc...
BACKGROUND: Lung adenocarcinoma (LUAD) is a heterogeneous tumor characterized by diverse genetic and...
Cancer immunotherapy has emerged as a novel clinical therapeutic option for a variety of solid tumor...
The characteristics of neutrophils play a crucial role in defining the tumor inflammatory environmen...
Anoikis-related genes (ANRGs) are crucial in the invasion and metastasis of breast cancer (BC). The...
Gliomas represent a highly aggressive class of tumors located in the brain. Despite the availability...
Pancreatic cancer remains one of the most lethal cancers, primarily due to its late diagnosis and li...
In this study, we aimed to investigate disparities in the tumor immune microenvironment (TME) betwee...
The digitization of health records and growing availability of tumour DNA sequencing provide an oppo...
Viruses are widely recognized to be intricately associated with both solid and hematological maligna...
Skin diseases are a significant global public health concern, affecting 21-85% of the world's popula...
Most patients with non-small cell lung cancer (NSCLC) are diagnosed at an advanced stage of the dise...
The escalating global incidence of allergy patients illustrates the growing impact of allergic issue...
To date, the public health system has been impacted by the increasing costs of many diagnostic and t...
BACKGROUND: Non-small cell lung cancer (NSCLC) is one of the leading causes of cancer mortality worl...
BACKGROUND: Glioma is a highly heterogeneous and poorly immunogenic malignant tumor, with limited ef...